Senior insider sale
Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC — senior position signals high conviction
$3.45M
22K shares
What this filing means
ONYIA JUDE plans to sell 22K shares of NEUROCRINE BIOSCIENCES INC valued at approximately $3.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001950047-26-005396
Officer· Chief Scientific Officer
Since Nov 2021
22K
Shares to sell
$3.45M
Approx. market value
11K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/1/2026
11KTotal acquired11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2026 | Exercise of Stock Options Cash | 11K | — |
| Total | 11K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11K
Market value
$1.71M
5/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11K
Market value
$1.74M
6/1/2026
Total
Units
22K
Value
$3.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/27/2026 | 11K | $1.71M | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 11K | $1.74M | NASDAQ | Planned |
| Total | 22K | $3.45M | ||